Item Type | Name |
Academic Article
|
A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
|
Academic Article
|
Case studies in severe psoriasis: A clinical strategy.
|
Academic Article
|
Modest innovations in psoriasis treatment?
|
Academic Article
|
Determinants of quality of life in patients with psoriasis: a study from the US population.
|
Academic Article
|
A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients.
|
Academic Article
|
Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
|
Academic Article
|
Correlates of health-related quality of life in women with severe facial blemishes.
|
Academic Article
|
The negative impact of psoriasis on the workplace.
|
Academic Article
|
The Acne Quality of Life Index (Acne-QOLI): development and validation of a brief instrument.
|
Academic Article
|
Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
|
Academic Article
|
Pterygium among Latino migrant farmworkers in North Carolina.
|
Academic Article
|
Comparison of different compliance behaviors in a clinical trial.
|
Academic Article
|
Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments.
|
Academic Article
|
Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial.
|
Academic Article
|
Severity levels in psoriasis: a separate 'very severe' category not required.
|
Academic Article
|
The prevalence of melasma and its association with quality of life in adult male Latino migrant workers.
|
Academic Article
|
Equating topical treatment of severe psoriasis to keeping money in a mattress.
|
Academic Article
|
Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
|
Academic Article
|
Psoralen plus ultraviolet A light phototherapy effectiveness.
|
Academic Article
|
Medication use and associated health care outcomes and costs for patients with psoriasis in the United States.
|
Academic Article
|
Consensus guidelines for the management of plaque psoriasis.
|
Academic Article
|
JAK inhibitors in psoriasis: a promising new treatment modality.
|
Academic Article
|
Risk of cardiovascular disorders in psoriasis patients: current and future.
|
Academic Article
|
Sleep disturbances in psoriasis.
|
Academic Article
|
Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study.
|
Academic Article
|
Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy?
|
Academic Article
|
Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice.
|
Academic Article
|
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.
|
Academic Article
|
Medication and health care service utilization related to depressive symptoms in older adults with psoriasis.
|
Academic Article
|
Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States.
|
Academic Article
|
Members of the national psoriasis foundation: more extensive disease and better informed about treatment options.
|
Academic Article
|
Decision points for the initiation of systemic treatment for psoriasis.
|
Academic Article
|
Incidence rates, costs, severity, and work-related factors of occupational dermatitis: a workers' compensation analysis of Oregon, 1990-1997.
|
Academic Article
|
Clobetasol propionate for psoriasis: are ointments really more potent?
|
Academic Article
|
Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
|
Academic Article
|
Nonlaser UVB-targeted phototherapy treatment of psoriasis.
|
Academic Article
|
Prescribing on the basis of subjective disease severity.
|
Academic Article
|
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.
|
Academic Article
|
Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review.
|
Academic Article
|
Targeted UV therapy in the treatment of psoriasis.
|
Academic Article
|
Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis.
|
Academic Article
|
Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis.
|
Academic Article
|
Utilization pattern of etanercept and its cost implications in moderate to severe psoriasis in a managed care population.
|
Academic Article
|
Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis.
|
Academic Article
|
Do topical retinoids cause acne to "flare"?
|
Academic Article
|
Prescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey.
|
Academic Article
|
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
|
Academic Article
|
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.
|
Academic Article
|
Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial.
|
Academic Article
|
Optimizing topical therapies for treating psoriasis: a consensus conference.
|
Academic Article
|
Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series.
|
Academic Article
|
Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.
|
Academic Article
|
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.
|
Academic Article
|
How patients experience and manage dryness and irritation from acne treatment.
|
Academic Article
|
An Internet-based survey and improvement of acne treatment outcomes.
|
Academic Article
|
Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris.
|
Academic Article
|
Comparative efficacy of biologics in psoriasis: a review.
|
Concept
|
Severity of Illness Index
|
Academic Article
|
The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.
|
Academic Article
|
Acitretin prescribing patterns in women of childbearing potential.
|
Academic Article
|
A double-blind, randomized clinical trial of 20% alpha/poly hydroxy acid cream to reduce scaling of lesions associated with moderate, chronic plaque psoriasis.
|
Academic Article
|
Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
|
Academic Article
|
Research gaps in psoriasis: opportunities for future studies.
|
Academic Article
|
Safety and tolerability of tumor necrosis factor-a inhibitors in psoriasis: a narrative review.
|
Academic Article
|
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
|
Academic Article
|
Measure of atopic dermatitis disease severity using actigraphy.
|
Academic Article
|
Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: a systematic review of published models and clinical practice guidelines.
|
Academic Article
|
Systemic therapies for psoriasis: an evidence-based update.
|
Academic Article
|
Pilot randomized-control trial to assess the effect product sampling has on adherence using adapalene/benzoyl peroxide gel in acne patients.
|
Academic Article
|
The economic burden of psoriasis: a systematic literature review.
|
Academic Article
|
Trends in systemic psoriasis treatment therapies from 1993 through 2010.
|
Academic Article
|
Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
|
Academic Article
|
The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials.
|
Academic Article
|
Patterns of medication utilization and costs associated with the use of etanercept, adalimumab, and ustekinumab in the management of moderate-to-severe psoriasis.
|
Academic Article
|
Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis.
|
Academic Article
|
Assessment of rosacea severity: A review of evaluation methods used in clinical trials.
|
Academic Article
|
Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study Design.
|
Academic Article
|
Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis.
|
Academic Article
|
Even well-controlled psoriasis patients have unmet treatment needs regardless of disease severity.
|
Academic Article
|
Dupilumab for the treatment of atopic dermatitis: A clinical trial review.
|
Academic Article
|
The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis.
|
Academic Article
|
Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice.
|
Academic Article
|
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.
|
Academic Article
|
Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary.
|
Academic Article
|
Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.
|
Academic Article
|
Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis.
|
Academic Article
|
A boxed warning for inadequate psoriasis treatment.
|
Academic Article
|
Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis.
|
Academic Article
|
Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis.
|
Academic Article
|
Topical 0.25% desoximetasone spray efficacy for moderate to severe plaque psoriasis: a randomized clinical trial.
|
Academic Article
|
Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs.
|
Academic Article
|
Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.
|
Academic Article
|
Severe and acute complications of biologics in psoriasis.
|
Academic Article
|
Treating Moderate-to-Severe Plaque Psoriasis With Guselkumab: A Review of Phase II and Phase III Trials.
|
Academic Article
|
Screening for depression in rosacea patients.
|
Academic Article
|
Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
|
Academic Article
|
Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.
|
Academic Article
|
The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis.
|
Academic Article
|
Measurement of Disease Severity in a Population of Rosacea Patients.
|
Academic Article
|
An assessment of the use of antihistamines in the management of atopic dermatitis.
|
Academic Article
|
Advances in treating psoriasis in the elderly with small molecule inhibitors.
|
Academic Article
|
Higher Psoriasis Skin Clearance Is Associated with Lower Annual Indirect Costs in the United States: A Post Hoc Analysis from the CLEAR Study.
|
Academic Article
|
Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders.
|
Academic Article
|
Validity and Reliability of a Rosacea Self-Assessment Tool.
|
Academic Article
|
Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States.
|
Academic Article
|
Characterization of Patients' Quality of Life and Experience in the Course of Acne Treatment.
|
Academic Article
|
Patient Costs Associated with Rosacea.
|
Academic Article
|
The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans.
|
Academic Article
|
Cost Per Additional Responder Associated With Ixekizumab and Etanercept in the Treatment of Moderate-to-Severe Psoriasis.
|
Academic Article
|
Rosacea Triggers: Alcohol and Smoking.
|
Academic Article
|
Economic Impact of Above-Label Dosing with Etanercept, Adalimumab, or Ustekinumab in Patients with Psoriasis.
|
Academic Article
|
Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States.
|
Academic Article
|
Hidradenitis suppurativa has an enormous impact on patients' lives.
|
Academic Article
|
Gastrointestinal Signs and Symptoms Related to Inflammatory Bowel Disease in Patients With Moderate-to-Severe Psoriasis
|
Academic Article
|
Relative efficacy of systemic treatments for atopic dermatitis.
|
Academic Article
|
Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon.
|
Academic Article
|
Is topical treatment effective for psoriasis in patients who failed topical treatment?
|
Academic Article
|
Topical Retinoids in Acne Vulgaris: A Systematic Review.
|
Academic Article
|
Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review.
|
Academic Article
|
Diet and psoriasis.
|
Academic Article
|
A novel ultraviolet B home phototherapy system: Efficacy, tolerability, adherence, and satisfaction.
|
Academic Article
|
Validation of a Hidradenitis Suppurativa Self-Assessment Tool.
|
Academic Article
|
Psoriasis and Atopic Dermatitis "Resistant" to Topical Treatment Responds Rapidly to Topical Desoximetasone Spray.
|
Academic Article
|
Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials.
|
Academic Article
|
Management of Residual Psoriasis in Patients on Biologic Treatment
|
Academic Article
|
Treatment Goals in Psoriasis: Which Outcomes Matter Most?
|
Academic Article
|
Adherence to topical treatment can improve treatment-resistant moderate psoriasis.
|
Academic Article
|
Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis.
|
Academic Article
|
Current and emerging biologics for the treatment of pediatric atopic dermatitis.
|
Academic Article
|
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
|
Academic Article
|
Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study.
|